好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Movement Disorders: Parkinson's Disease Treatment

Wednesday 04/28/04
04:00 PM - 05:15 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Movement Disorders
No CME available
Event Timeline
04:00 PM - 05:15 PM Abstract 001 - The Long Term Effect of Glial Derived Neurotrophic Factor Infusions on [sup]18[/sup]F-dopa Uptake in Parkinson's Disease
04:00 PM - 05:15 PM Abstract 002 - Effect on Plasma Homocysteine of Levodopa Initiation, and the Motor, Affective and Cognitive Associations of Hyperhomocysteinemia in Parkinson's Disease
04:00 PM - 05:15 PM Abstract 003 - Inhibition of the Dopamine Transporter Augments the Effects of Levodopa in Parkinson's Disease
04:00 PM - 05:15 PM Abstract 004 - A Comparative Randomised Study of Rasagiline Versus Placebo or Entacapone as Adjunct to Levodopa in Parkinson[rsquo]s Disease (PD) Patients with Motor Fluctuations (the LARGO Study)
04:00 PM - 05:15 PM Abstract 005 - Effects of Nocturnal Pergolide on Sleep in Levodopa Treated Parkinson Disease Patients: A Randomized, Placebo-Controlled Trial
Faculty Disclosures
Stewart A. Factor, DO, FAAN Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Voyager. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Prelinia. The institution of Dr. Factor has received research support from Medtronics. The institution of Dr. Factor has received research support from Boston Scientific. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Alan R. Hirsch, MD, FACP Dr. Hirsch has nothing to disclose.
Katherine D. Mathews, MD, FAAN Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
John F. Rothrock, MD The institution of Dr. Rothrock has received research support from AbbVie.
Jeffrey C. Wagner, MD Dr. Wagner has nothing to disclose.
Diane A. Andress-Rothrock No disclosure on file
Xuan Li No disclosure on file
No disclosure on file
Ryan Hays, MD, MBA, FAES, FAAN Dr. Hays has nothing to disclose.
Mark Agostini, MD Dr. Agostini has nothing to disclose.
Niyatee Samudra, MD Dr. Samudra has nothing to disclose.
Amanda Tinsley, MD No disclosure on file
Omar R. Olhaye, PharmD No disclosure on file
Brianna Brun Dr. Brun has received research support from National Institute of Neurological Disorders and Stroke.
Julia A. Collison No disclosure on file
Russell Knoth No disclosure on file
Kristin Salottolo, MPH Ms. Salottolo has nothing to disclose.
Michelle Whaley No disclosure on file
Joan B. Cracco, MD No disclosure on file
Radha Giridharan, MD, MBBS No disclosure on file